Tratamiento quirúrgico de quilotórax postrasplante pulmonar por linfangioleiomiomatosis / Surgical Treatment of Chylothorax After Lung Transplantation for Lymphangioleiomyomatosis

No disponible

Early Surgical Management of Bronchial Dehiscence After Single-Lung Transplantation: A Case Report.

Anastomotic airway complications after lung transplantation affect up to 20% of patients. Bronchial stenosis is the most frequent complication, while dehiscence of bronchial anastomosis is a rarely seen complication, with report incidences between 1% and 10%. Despite its low incidence, dehiscence of bronchial anastomoses remains a disastrous complication in the posttransplantation period without a well-established management protocol. We present a challenging case of complete bronchial dehiscence after unilateral lung transplantation in a patient with interstitial lung fibrosis (ILF) that occurred on postoperative day 10. The dehiscence was diagnosed early and the patient's status was stable for repeat thoracotomy, therefore, an early surgical approach was preferable to conservative management or bronchoscopy. Aggressive early surgical management in a stable patient allows for complete debridement with removal of the detritus that impedes correct anastomosis healing and permits the removal of microbial vegetations with successful results.

Thoracotomy Wound Dehiscence After Lung Transplant Is an Effective Surgical Solution: A Case Report.

Post-thoracotomy wound dehiscence after a lung transplant carries with it morbidity in the postoperative period. While this complication has been widely reported in the literature after a clamshell incision, the thoracotomy dehiscence's surgical solution has not received much emphasis. We present an original technical solution to deal with this complication, performed successfully in a 62-year-old woman diagnosed as having idiopathic pulmonary hemosiderosis after a single lung transplant. This surgical treatment consists of necrotic rib tissue removal, pleural effusion drainage, pulmonary adhesion removal, and chest wall defect reparation with bioabsorbable mesh. This operative technique results safe and effective for thoracotomy dehiscence reparation.

¿Es una buena opción terapéutica la cirugía pulmonar en pacientes mayores de 80 años? / Is lung surgery a good option for octogenarians?

INTRODUCCIÓN: El número de pacientes geriátricos con cáncer de pulmón se espera que aumente en las próximas décadas, especialmente por encima de los 80 años de edad, por tanto es importante conocer los límites terapéuticos. ¿Es una buena opción terapéutica la cirugía pulmonar en mayores de 80 años?. OBJETIVO: Mostrar nuestros resultados en las resecciones pulmonares realizadas a mayores de 80 años para evaluar la seguridad y el pronóstico a corto plazo en estos pacientes. MATERIAL Y MÉTODOS: Estudio retrospectivo de 21 pacientes sometidos a resección pulmonar entre octubre de 1999 a octubre de 2011. RESULTADOS: De 21 pacientes con edad de 82 ± 2 años, en los que se realizó 13 lobectomías, 5 resecciones transegmentarias, 2 segmentectomías regladas y una neumonectomía, las complicaciones postoperatorias (28,6%) fueron: 66,6% respiratorias, 16,7% cardíacas y 16,7% digestivas. La mortalidad perioperatoria fue del 9,5% (2). Observamos significación estadística entre la mortalidad postoperatoria y la edad (p = 0,023), o la realización de neumonectomía (p = 0,002). Estudiamos la EPOC como factor de riesgo de mortalidad apreciando significación estadística con la necesidad de UCI (p < 0,007) y la aparición de complicaciones (p < 0,044). CONCLUSIONES: La cirugía de resección pulmonar en mayores de 80 años es una buena opción terapéutica en pacientes seleccionados. En nuestra experiencia el carcinoma broncogénico epidermoide fue el más frecuente. La cirugía de elección fue la lobectomía, que demuestra ser una técnica segura con una baja tasa de complicaciones postoperatorias en pacientes añosos. La neumonectomía debe evitarse en estos pacientes, ya que hemos observado una asociación significativa con la mortalidad perioperatoria

INTRODUCTION: The number of geriatric patients with lung cancer is expected to increase in the next few years, especially patients over 80, and therefore it is important to know where the therapeutic limits should be drawn. Is surgery a good option in patients over 80? OBJECTIVE: To show the results of lung resection in patients over 80 years of age to evaluate the safety and short-term results. MATERIAL AND METHODS: Retrospective study of 21 patients who underwent lung resection between October 1999 and October 2011. RESULTS: The mean age of the patients was 82 ± 2; 13 lobectomies were performed,5 transegmental resections, 2 segmentectomies, and 1 pneumonectomy. Postoperative complications (28.6%) were: respiratory 66.6%, cardiological 16.7% and digestive 16,7%. Perioperative mortality was 9,5% (2). There was a significant association between mortality and age (P = .023), or pneumonectomy (P = .002). We studied COPD as a risk factor for mortality and found a statistically significant relation with the need for ICU (P < .007), and the appearance of complications (P < .044). CONCLUSIONS: Resective lung surgery is feasible and safe in selected patients over 80 years of age. In our experience, squamous cell carcinoma was the most frequent tumor. The most common procedure was lobectomy which is a safe technique with a low complicaction rate in elderly patients. Pneumonectomy s hould be avoided, as we have found a significant association with perioperative mortality

Periareolar approach for thoracoscopic lobectomy.

In recent years advances in video-assisted thoracoscopic surgery have been aimed at reducing the number of video surgery ports, and especially major lung resections pose the greatest challenge. We describe a new minimally invasive as well as aesthetic approach for thoracoscopic lobectomy. The technique poses no difficulty for the surgeon and has certain advantages over other videothoracoscopic approaches.

Is lung surgery a good option for octogenarians?

INTRODUCTION: The number of geriatric patients with lung cancer is expected to increase in the next few years, especially patients over 80, and therefore it is important to know where the therapeutic limits should be drawn. Is surgery a good option in patients over 80? OBJECTIVE: To show the results of lung resection in patients over 80 years of age to evaluate the safety and short-term results. MATERIAL AND METHODS: Retrospective study of 21 patients who underwent lung resection between October 1999 and October 2011. RESULTS: The mean age of the patients was 82 ± 2; 13 lobectomies were performed,5 transegmental resections, 2 segmentectomies, and 1 pneumonectomy. Postoperative complications (28.6%) were: respiratory 66.6%, cardiological 16.7% and digestive 16,7%. Perioperative mortality was 9,5% (2). There was a significant association between mortality and age (P=.023), or pneumonectomy (P=.002). We studied COPD as a risk factor for mortality and found a statistically significant relation with the need for ICU (P<.007), and the appearance of complications (P<.044). CONCLUSIONS: Resective lung surgery is feasible and safe in selected patients over 80 years of age. In our experience, squamous cell carcinoma was the most frequent tumor. The most common procedure was lobectomy which is a safe technique with a low complication rate in elderly patients. Pneumonectomy should be avoided, as we have found a significant association with perioperative mortality.

Bronchiectasis due to pulmonary artery aneurysm.

Pulmonary artery aneurysm (PAA) is a rare entity. We report what we believe to be the first case of bronchiectasis resulting from a PAA, which in turn developed after a previous Senning procedure for transposition of the great vessels during infancy. The patient had bronchiectasis secondary to compression of the left main bronchus because of a PAA. Bronchiectasis is a condition indicating lung resection. Despite the patient receiving medical therapy to treat recurrent pneumonia, lobectomy was necessary to prevent this and other possible complications.

Neumotórax espontáneo: Etiopatogenia, repercusión funcionaly epidemiología / No disponible

No disponible